Literature DB >> 34216652

PM2.5 as a potential risk factor for autism spectrum disorder: Its possible link to neuroinflammation, oxidative stress and changes in gene expression.

Suk-Yu Yau1, Hao-Xian Lu2, Tatia M C Lee3, Hai Guo4, Chetwyn C H Chan5.   

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental disorder characterized by behavioral deficits including impairments in social communication, social interaction, and repetitive behaviors. Because the etiology of ASD is still largely unknown, there is no cure for ASD thus far. Although it has been established that genetic components play a vital role in ASD development, the influence of epigenetic regulation induced by environmental factors could also contribute to ASD susceptibility. Accumulated evidence has suggested that exposure to atmospheric particulate matter (PM) in polluted air could affect neurodevelopment, thus possibly leading to ASD. Particles with a size of 2.5 μm (PM2.5) or less have been shown to have negative effects on human health, and could be linked to ASD symptoms in children. This review summarizes evidence from clinical and animal studies to demonstrate the possible linkage between PM2.5 exposure and the incidence of ASD in children. An attempt was made to explore the possible mechanisms of this linkage, including changes of gene expression, oxidative stress and neuroinflammation induced by PM2.5 exposure.
Copyright © 2021. Published by Elsevier Ltd.

Entities:  

Keywords:  Autism spectrum disorder; Changes of gene expression; Neuroinflammation; Oxidative stress; PM(2.5)

Year:  2021        PMID: 34216652     DOI: 10.1016/j.neubiorev.2021.06.043

Source DB:  PubMed          Journal:  Neurosci Biobehav Rev        ISSN: 0149-7634            Impact factor:   8.989


  2 in total

1.  C1q/TNF-related protein-1: Potential biomarker for early diagnosis of autism spectrum disorder.

Authors:  Hamed Raeisy; Paria Bayati; Farshid Noorbakhsh; Mitra Hakim Shooshtari; Mehrdad Eftekhar Ardebili; Mehdi Shekarabi; Nazanin Mojtabavi
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

2.  Nonpharmaceutical therapy for autism spectrum disorder: A protocol for systematic review and network meta-analysis.

Authors:  Xin Jiang; Min Song; Weixun Qin; Jiang Xiao; Xiaoqing Xu; Qing Yuan
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.